Article Text

Download PDFPDF

274 Prevalence of anti-dfs70 antibodies in a colombian cohort: a case-control study
  1. S Arteaga1,
  2. T Urrego2,
  3. LM Peñaranda3,
  4. A Londoño4,
  5. ML Cardenas4,
  6. AL Vanegas1,
  7. CH Muñoz1,
  8. M Escobar1,
  9. W Rojas1,
  10. G Vásquez1,2,
  11. LA González1,
  12. C Perez Koller3 and
  13. JA Gómez-Puerta1,2,4
  1. 1Universidad de Antioquia, Sección de Reumatología, Medellin, Colombia
  2. 2Universidad de Antioquia, Grupo de Inmunología Celular e Inmunogenética, Medellin, Colombia
  3. 3Werfen, Inova Diagnostics, Bogotá, Colombia
  4. 4Dinamica IPS, Autoinmunidad, Medellín, Colombia


Background and aims Anti-dense fine speckled 70 (anti-DFS70) antibodies were initially identified as an ANA IIF pattern from patients with interstitial cystitis; however, some recent studies showed that anti-DFS70 antibodies are common among ANA positive individuals with no evidence of systemic autoimmune disease (SAD)(Mahler M. 2012). Information of anti-DFS70 in Latin-American countries is very limited. We determined the prevalence of Anti-DFS70 antibodies in a Colombian cohort.

Methods We evaluated individuals≥18 years old, including 100 SLE patients, 102 SADs, 200 healthy controls, and 56 subjects suspected of having autoimmune disease with ANA positive and negative anti ds-DNA antibodies. The presence of anti-DFS70 antibodies was determined by QUANTA Flash by chemiluminescent techniques (Inova/Werfen, San Diego)

Results Our final cohort included 458 samples. The mean age of SLE patients was 33±12 years, for SADs was 41±19 and for healthy controls was 36±10 years. The main diagnoses of SAD were: Vasculitis (n=28), RA (n=21), Systemic sclerosis (n=12), primary antiphospholipid syndrome (n=11), dermatomyositis (n=10) among others. Racial/ethnic breakdown was: 76% Mestizo and 20% Afro-latin Americans. Anti-DFS70 antibodies were positive in 1.8% of subjects with ANAs positive/anti DNA negative, in 1% of SLE patients, 0.9% of patients with other SADs and in 0.5% of healthy controls. Given the low prevalence of anti-DFS70 antibodies, no clinical correlations were possible.

Conclusions Despite anti-DFS70 antibodies are a good diagnostic tool for discrimination among healthy individuals and SADs (including SLE), we found a very low prevalence of anti-DFS70 antibodies in our Colombian cohort.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.